Page 119 | Certara

Press Coverage

FDA’s Project Optimus Guidance: Highlights and Tips for Success for Oncology Drug Developers

2023 guidance from FDA on dosages in oncology provides further context on expectations with Project…

CertaraMay 3, 2023

Blog

Collaborating with CROs within the DMTA cycle

Important factors when collaborating with a CRO It is becoming increasingly popular for drug discovery…

CertaraApril 29, 2023

Blog

Local and Global Models For Predicting Properties of Small Molecules

Which type of model has the most potential for success? The obvious answer is all…

CertaraApril 28, 2023

Blog

How do predicted pKa and solubility values compare to reality?

Discover why Chemaxon's predictions are well accepted and widely used both in industry settings and…

CertaraApril 27, 2023

Blog

SEND Dataset Quality Control: Best Practices & Recommendations

In this blog, Senior Product Management Director Peggy Zorn explores best practices & recommendations for…

CertaraApril 25, 2023

On-Demand Webinar

How digital communication tools will revolutionize your medical conversation

Medical Affair, Market Access, and Sales & Marketing teams at most of pharmaceutical companies use…

CertaraApril 24, 2023

Blog

Cloud calculation exemplified

Augmenting chemical structures with calculated properties using dedicated, secure and scalable services.

CertaraApril 24, 2023

Press Coverage

Overcoming CMC challenges in cell and gene therapy: part II

Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven…

CertaraApril 22, 2023

Case Study

Using MBMA to run virtual “head-to-head trials”

Osteoporosis is common in post-menopausal women. The long-term sequelae of osteoporosis include bone fractures, particularly…

CertaraApril 21, 2023

Blog

Innovating Sales & Marketing Digital Engagement for Pharma and Med Tech

The regulatory environment for Pharma and Med Tech creates business challenges for digital engagement. Many…

CertaraApril 21, 2023

FDA’s Project Optimus Guidance: Highlights and Tips for Success for Oncology Drug Developers

Collaborating with CROs within the DMTA cycle

Local and Global Models For Predicting Properties of Small Molecules

How do predicted pKa and solubility values compare to reality?

SEND Dataset Quality Control: Best Practices & Recommendations

How digital communication tools will revolutionize your medical conversation

Cloud calculation exemplified

Overcoming CMC challenges in cell and gene therapy: part II

Using MBMA to run virtual “head-to-head trials”

Innovating Sales & Marketing Digital Engagement for Pharma and Med Tech

Newsletter sign up

Quick links

Solutions

Contact